To confirm that higher GRHL2 expression is an unfavorable metastatic factor related to histological grade of the breast tumor, we evaluated a collection of six independent datasets pertaining to primary human breast cancer [15], containing 947 independent primary breast tumor samples [16]–[21] (Fig. 1C–1E). This evidence concerns the gene GRHL2 and breast cancer.